World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
26671
World Ranking
16544
National Ranking
521

Overview

Seiji Fukumoto is affiliated with the University of Tokushima in Japan and has focused their research primarily on Medicine, with 165 publications in this field. Their specialized interests include Nephrology, Oncology, Molecular Biology, Genetics, and Pulmonary and Respiratory Medicine.

Their research concentrates on topics such as Parathyroid Disorders and Treatments, Bone Health and Treatments, Genetic Syndromes and Imprinting, Medical Imaging and Pathology Studies, Bone Health and Osteoporosis Research, Fibroblast Growth Factor Research, and Vitamin D Research Studies.

Frequent co-authors collaborating with Fukumoto include:

  • Toshio Matsumoto
  • Nobuaki Ito
  • Yuichi Takashi
  • Erik A. Imel
  • Maria Luisa Brandi

They have published extensively in several notable venues. The most frequent publication venues are:

  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Journal of Bone and Mineral Research
  • Journal of Bone and Mineral Metabolism
  • The Journal of Clinical Endocrinology & Metabolism
  • Calcified Tissue International

Some selected recent papers authored or co-authored by Seiji Fukumoto include:

  • FGF23-related hypophosphatemic rickets/osteomalacia: diagnosis and new treatment, 2020, Journal of Molecular Endocrinology
  • Interim Analysis of a Phase 2 Open-Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor-Induced Osteomalacia, 2020, Journal of Bone and Mineral Research
  • Tumor-induced Osteomalacia: A Comprehensive Review, 2022, Endocrine Reviews
  • Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases, 2022, Calcified Tissue International
  • Approach to patients with hypophosphataemia, 2020, The Lancet Diabetes & Endocrinology

Best Publications

  • Klotho converts canonical FGF receptor into a specific receptor for FGF23

    Itaru Urakawa;Yuji Yamazaki;Takashi Shimada;Kousuke Iijima

  • FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.

    Takashi Shimada;Hisashi Hasegawa;Yuji Yamazaki;Takanori Muto

  • Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism

    Takashi Shimada;Makoto Kakitani;Yuji Yamazaki;Hisashi Hasegawa

  • Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

    Takashi Shimada;Satoru Mizutani;Takanori Muto;Takashi Yoneya

  • Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.

    Yuji Yamazaki;Ryo Okazaki;Minako Shibata;Yukihiro Hasegawa

  • Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.

    Takashi Shimada;Takanori Muto;Itaru Urakawa;Takashi Yoneya

  • FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.

    Takashi Shimada;Itaru Urakawa;Yuji Yamazaki;Hisashi Hasegawa

  • Association between activating mutations of calcium-sensing receptor and Bartter's syndrome

    Sumiyo Watanabe;Seiji Fukumoto;Hangil Chang;Yasuhiro Takeuchi

  • Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism.

    Takashi Shimada;Yuji Yamazaki;Motoo Takahashi;Hisashi Hasegawa

  • Clinical Practice Guideline for the Management of Chronic Kidney Disease-Mineral and Bone Disorder

    Masafumi Fukagawa;Keitaro Yokoyama;Fumihiko Koiwa;Masatomo Taniguchi

  • Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease

    Hisashi Hasegawa;Nobuo Nagano;Itaru Urakawa;Yuji Yamazaki

  • Ghrelin directly regulates bone formation.

    Nobuhiro Fukushima;Reiko Hanada;Hitoshi Teranishi;Yoshihiko Fukue

  • Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

    Takashi Shigematsu;Junichiro James Kazama;Takeyoshi Yamashita;Seiji Fukumoto

  • Bone as an endocrine organ

    Seiji Fukumoto;T. John Martin

  • Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways.

    Yusuke Shinoda;Masayuki Yamaguchi;Naoshi Ogata;Toru Akune

  • Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats

    T Nakamura;K Hanada;M Tamura;T Shibanushi

  • A microRNA regulatory mechanism of osteoblast differentiation.

    Hiroyuki Inose;Hiroki Ochi;Ayako Kimura;Koji Fujita

  • Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23

    Yuji Yamazaki;Taro Tamada;Noriyuki Kasai;Itaru Urakawa

  • Therapeutic Effects of Anti-FGF23 Antibodies in Hypophosphatemic Rickets/Osteomalacia

    Yukiko Aono;Yuji Yamazaki;Junichi Yasutake;Takehisa Kawata

  • Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

    Seiji Fukumoto;Takeyoshi Yamashita

Frequent Co-Authors

Toshiro Fujita
Toshiro Fujita University of Tokyo
Toshio Matsumoto
Toshio Matsumoto University of Tokushima
Masafumi Fukagawa
Masafumi Fukagawa Tokai University
Yasuhiro Takeuchi
Yasuhiro Takeuchi University College London
Takashi Shimada
Takashi Shimada Nippon Medical School
Toshitsugu Sugimoto
Toshitsugu Sugimoto Shimane University
Masaomi Nangaku
Masaomi Nangaku University of Tokyo
Kohei Miyazono
Kohei Miyazono University of Tokyo
Shigeaki Kato
Shigeaki Kato University of Tokyo
Toshiki Watanabe
Toshiki Watanabe University of Tokyo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine often opens doors to related fields that offer flexibility and variety. For those with a bachelor’s degree seeking a shift into nursing, online MSN programs for non nurses present an accelerated option—allowing quicker entry into advanced practice roles.

Entry requirements can vary among programs. Some prospective nurses seek out what is the easiest nursing school to get into to streamline their application process and increase their chances of acceptance. Additionally, applicants concerned about standardized testing may prefer nursing schools that don't require teas or hesi examinations.

Not every medical career demands patient care. Allied health degrees, such as those in health informatics, offer options for aspiring professionals. For example, those interested in administrative roles may consider accredited medical billing and coding schools with financial aid—an avenue for entering healthcare without direct clinical responsibilities.

Exploring these pathways can help students align their academic goals with available opportunities in the ever-evolving healthcare industry.

Best Scientists Citing Seiji Fukumoto

Trending Scientists

Recently Published Articles